Ellagic acid: A potent glyoxalase-I inhibitor with a unique scaffold

The glyoxalase system, particularly glyoxalase-I (GLO-I), has been approved as a potential target for cancer treatment. In this study, a set of structurally diverse polyphenolic natural compounds were investigated as potential GLO-I inhibitors. Ellagic acid was found, computationally and experimenta...

Full description

Saved in:
Bibliographic Details
Main Authors: Al-Shar’i Nizar A., Al-Balas Qosay A., Hassan Mohammad A., El-Elimat Tamam M., Aljabal Ghazi A., Almaaytah Ammar M.
Format: Article
Language:English
Published: Sciendo 2021-03-01
Series:Acta Pharmaceutica
Subjects:
Online Access:https://doi.org/10.2478/acph-2021-0005
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832572164251844608
author Al-Shar’i Nizar A.
Al-Balas Qosay A.
Hassan Mohammad A.
El-Elimat Tamam M.
Aljabal Ghazi A.
Almaaytah Ammar M.
author_facet Al-Shar’i Nizar A.
Al-Balas Qosay A.
Hassan Mohammad A.
El-Elimat Tamam M.
Aljabal Ghazi A.
Almaaytah Ammar M.
author_sort Al-Shar’i Nizar A.
collection DOAJ
description The glyoxalase system, particularly glyoxalase-I (GLO-I), has been approved as a potential target for cancer treatment. In this study, a set of structurally diverse polyphenolic natural compounds were investigated as potential GLO-I inhibitors. Ellagic acid was found, computationally and experimentally, to be the most potent GLO-I inhibitor among the tested compounds which showed an IC50 of 0.71 mmol L−1. Its binding to the GLO-I active site seemed to be mainly driven by ionic interaction via its ionized hydroxyl groups with the central Zn ion and Lys156, along with other numerous hydrogen bonding and hydrophobic interactions. Due to its unique and rigid skeleton, it can be utilized to search for other novel and potent GLO-I inhibitors via computational approaches such as pharmacophore modeling and similarity search methods. Moreover, an inspection of the docked poses of the tested compounds showed that chlorogenic acid and dihydrocaffeic acid could be considered as lead compounds worthy of further optimization.
format Article
id doaj-art-e091c6c4b5554772b51df0a32144250c
institution Kabale University
issn 1846-9558
language English
publishDate 2021-03-01
publisher Sciendo
record_format Article
series Acta Pharmaceutica
spelling doaj-art-e091c6c4b5554772b51df0a32144250c2025-02-02T11:49:57ZengSciendoActa Pharmaceutica1846-95582021-03-0171111513010.2478/acph-2021-0005acph-2021-0005Ellagic acid: A potent glyoxalase-I inhibitor with a unique scaffoldAl-Shar’i Nizar A.0Al-Balas Qosay A.1Hassan Mohammad A.2El-Elimat Tamam M.3Aljabal Ghazi A.4Almaaytah Ammar M.5Department of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy, Jordan University of Science and Technology, P.O. Box 3030 Irbid 22110, JordanDepartment of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy, Jordan University of Science and Technology, P.O. Box 3030 Irbid 22110, JordanDepartment of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy, Jordan University of Science and Technology, P.O. Box 3030 Irbid 22110, JordanDepartment of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy, Jordan University of Science and Technology, P.O. Box 3030 Irbid 22110, JordanDepartment of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy, Jordan University of Science and Technology, P.O. Box 3030 Irbid 22110, JordanDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Jordan University of Science and Technology, P.O. Box 3030, Irbid 22110, JordanThe glyoxalase system, particularly glyoxalase-I (GLO-I), has been approved as a potential target for cancer treatment. In this study, a set of structurally diverse polyphenolic natural compounds were investigated as potential GLO-I inhibitors. Ellagic acid was found, computationally and experimentally, to be the most potent GLO-I inhibitor among the tested compounds which showed an IC50 of 0.71 mmol L−1. Its binding to the GLO-I active site seemed to be mainly driven by ionic interaction via its ionized hydroxyl groups with the central Zn ion and Lys156, along with other numerous hydrogen bonding and hydrophobic interactions. Due to its unique and rigid skeleton, it can be utilized to search for other novel and potent GLO-I inhibitors via computational approaches such as pharmacophore modeling and similarity search methods. Moreover, an inspection of the docked poses of the tested compounds showed that chlorogenic acid and dihydrocaffeic acid could be considered as lead compounds worthy of further optimization.https://doi.org/10.2478/acph-2021-0005ellagic acidglyoxalase-izinc-bindinganticancermolecular dockingmm-gbmv
spellingShingle Al-Shar’i Nizar A.
Al-Balas Qosay A.
Hassan Mohammad A.
El-Elimat Tamam M.
Aljabal Ghazi A.
Almaaytah Ammar M.
Ellagic acid: A potent glyoxalase-I inhibitor with a unique scaffold
Acta Pharmaceutica
ellagic acid
glyoxalase-i
zinc-binding
anticancer
molecular docking
mm-gbmv
title Ellagic acid: A potent glyoxalase-I inhibitor with a unique scaffold
title_full Ellagic acid: A potent glyoxalase-I inhibitor with a unique scaffold
title_fullStr Ellagic acid: A potent glyoxalase-I inhibitor with a unique scaffold
title_full_unstemmed Ellagic acid: A potent glyoxalase-I inhibitor with a unique scaffold
title_short Ellagic acid: A potent glyoxalase-I inhibitor with a unique scaffold
title_sort ellagic acid a potent glyoxalase i inhibitor with a unique scaffold
topic ellagic acid
glyoxalase-i
zinc-binding
anticancer
molecular docking
mm-gbmv
url https://doi.org/10.2478/acph-2021-0005
work_keys_str_mv AT alsharinizara ellagicacidapotentglyoxalaseiinhibitorwithauniquescaffold
AT albalasqosaya ellagicacidapotentglyoxalaseiinhibitorwithauniquescaffold
AT hassanmohammada ellagicacidapotentglyoxalaseiinhibitorwithauniquescaffold
AT elelimattamamm ellagicacidapotentglyoxalaseiinhibitorwithauniquescaffold
AT aljabalghazia ellagicacidapotentglyoxalaseiinhibitorwithauniquescaffold
AT almaaytahammarm ellagicacidapotentglyoxalaseiinhibitorwithauniquescaffold